P591 Therapeutic drug monitoring in Paediatric inflammatory bowel disease on maintenance infliximab and adalimumab treatment improves clinical remission with a proactive approach

Autor:	S. Chadokufa, B. Huggett, Neil Shah, A. Zambrano Perez, S. Sider, N. Acton, M. Baycheva, T. Sawney, Fevronia Kiparissi
Rok vydání:	2017
Předmět:	medicine.medical_specialty medicine.diagnostic_test business.industry Gastroenterology General Medicine medicine.disease Inflammatory bowel disease Infliximab Therapeutic drug monitoring medicine Adalimumab Intensive care medicine business medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 11:S381-S382
ISSN:	1876-4479 1873-9946
DOI:	10.1093/ecco-jcc/jjx002.715
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1135515ca21f536b82ff7ded55a339b3 https://doi.org/10.1093/ecco-jcc/jjx002.715 Zobrazit plný text záznamu